Results 121 to 130 of about 25,894 (252)
Link Prediction in Multipartite Graphs With Application to Drug Repositioning Studies. [PDF]
Chen C +4 more
europepmc +1 more source
Magneto‐responsive fibers and fabrics for soft systems
Abstract The combination of functional materials in fiber form has led to a surge in the integration of functional fibers and fabrics into soft systems that span sensing, communication, and actuation domains. A key subset is magnetic fibers and fabrics.
Hanlin Zhu +8 more
wiley +1 more source
COMPUTATIONAL DRUG REPOSITIONING [PDF]
ZHIYONG LU +2 more
openaire +1 more source
A fused deep learning approach to transform drug repositioning. [PDF]
Li K +9 more
europepmc +1 more source
This review systematically summarizes two‐dimensional layered and nonlayered oxides, focusing on their synthesis, properties, and post‐Moore applications in transistors, gate dielectrics, optoelectronics, and ferroelectric/magnetic devices. It also discusses challenges including scalable growth and interface engineering, along with future industrial ...
Xinjie Hou +5 more
wiley +1 more source
A case-based explainable graph neural network framework for mechanistic drug repositioning. [PDF]
Gonzalez-Cavazos AC +3 more
europepmc +1 more source
Piezoelectric materials are reviewed as active platforms for medical ultrasound, bridging electromechanical fundamentals, transducer architectures, and biomedical applications. Material–device co‐design is emphasized as the key to high‐performance diagnosis, therapy, monitoring, wearable ultrasound, and emerging ultrasound‐responsive functions ...
Jianan Li, Qing Wan
wiley +1 more source
Drug repositioning in metastatic prostate cancer based on protein- protein interaction network: Computational and in vitro analysis. [PDF]
Saadat Z +3 more
europepmc +1 more source
ABSTRACT Clinical trials combining radiotherapy (RT) with immune checkpoint blockade (ICB) have shown improved outcomes in only a fraction of patients, and optimal strategies for integrating these modalities remain under intense investigation. With a few exceptions, phase III combination trials have yielded disappointing results.
Xuanwei Zhang +10 more
wiley +1 more source
An integrated drug repositioning analysis identifies rosiglitazone as a treatment for sarcopenia. [PDF]
Liang S, Liu Y, Xiao HM, Deng HW.
europepmc +1 more source

